ACIU Projected Dividend Yield
Ord/AC Immune SA ( NASDAQ : ACIU )AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. Co. focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). Co.'s pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. 20 YEAR PERFORMANCE RESULTS |
ACIU Dividend History Detail ACIU Dividend News ACIU Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |